Proposed Federal Workplace Drug Testing Guidelines
Summary
The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a proposed rule to update federal workplace drug testing guidelines. This consultation seeks public comment on the proposed changes to these guidelines.
What changed
SAMHSA has published a proposed rule to revise its guidelines for federal workplace drug testing programs. The proposal outlines potential updates to testing methodologies, laboratory procedures, and the types of substances that may be tested for. This action is a significant step towards modernizing federal drug-free workplace standards and ensuring the integrity of testing processes across federal agencies.
Regulated entities, particularly federal agencies and their contractors, should review the proposed changes and consider submitting comments. The comment period deadline is crucial for influencing the final rule. Failure to comply with updated guidelines once finalized could lead to non-compliance findings and potential sanctions, although specific penalties are not detailed in this proposal.
What to do next
- Review proposed changes to federal workplace drug testing guidelines
- Submit comments to SAMHSA by the specified deadline
Source document (simplified)
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Substance Abuse and Mental Health Services Administration publishes new changes.